RegentAtlantic Capital’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$699K Sell
3,340
-389
-10% -$81.4K 0.02% 378
2022
Q2
$879K Sell
3,729
-395
-10% -$93.1K 0.03% 338
2022
Q1
$740K Sell
4,124
-288
-7% -$51.7K 0.02% 373
2021
Q4
$953K Sell
4,412
-137
-3% -$29.6K 0.03% 331
2021
Q3
$840K Sell
4,549
-983
-18% -$182K 0.03% 332
2021
Q2
$992K Sell
5,532
-1,354
-20% -$243K 0.03% 295
2021
Q1
$1.15M Sell
6,886
-641
-9% -$107K 0.04% 259
2020
Q4
$1.14M Buy
7,527
+1,411
+23% +$214K 0.05% 228
2020
Q3
$618K Buy
6,116
+2,962
+94% +$299K 0.03% 294
2020
Q2
$382K Buy
+3,154
New +$382K 0.02% 342
2019
Q3
Sell
-3,378
Closed -$264K 458
2019
Q2
$264K Sell
3,378
-1,715
-34% -$134K 0.02% 378
2019
Q1
$598K Sell
5,093
-50
-1% -$5.87K 0.04% 271
2018
Q4
$560K Sell
5,143
-526
-9% -$57.3K 0.05% 268
2018
Q3
$725K Sell
5,669
-498
-8% -$63.7K 0.06% 255
2018
Q2
$698K Sell
6,167
-2,265
-27% -$256K 0.06% 249
2018
Q1
$947K Sell
8,432
-3,777
-31% -$424K 0.08% 217
2017
Q4
$1.81M Sell
12,209
-714
-6% -$106K 0.15% 157
2017
Q3
$1.51M Buy
12,923
+315
+2% +$36.9K 0.13% 168
2017
Q2
$1.64M Sell
12,608
-1,795
-12% -$233K 0.15% 153
2017
Q1
$1.95M Sell
14,403
-1,130
-7% -$153K 0.18% 141
2016
Q4
$2.23M Buy
15,533
+2,785
+22% +$399K 0.22% 124
2016
Q3
$1.51M Sell
12,748
-815
-6% -$96.2K 0.16% 150
2016
Q2
$1.44M Buy
13,563
+1,285
+10% +$136K 0.14% 148
2016
Q1
$1.37M Buy
+12,278
New +$1.37M 0.15% 140
2015
Q1
Sell
-313
Closed -$40.5K 917
2014
Q4
$40.5K Buy
+313
New +$40.5K ﹤0.01% 628